News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Ruzanna Papyan: Julia Hoveyan on Access to Novel Therapies in the POEM Region at 4th POEM Scientific Meeting
Ruzanna Papyan and Julia Hoveyan
May 3, 2025, 08:03

Ruzanna Papyan: Julia Hoveyan on Access to Novel Therapies in the POEM Region at 4th POEM Scientific Meeting

Ruzanna Papyan, Pediatric Oncologist and clinical research physician at the Pediatric Cancer and Blood Disorders Center of Armenia, shared a post on LinkedIn:

“So proud of my dear friend and colleague Julia Hoveyan who delivered an excellent presentation on access to novel therapies in the POEM region during the POEM Group 4th scientific meeting.
Julieta has been one of the founders of the neuro-oncology service in Armenia, and her commitment, passion, and tireless work have shaped the path we’re on today.
Grateful to walk this journey with you, Julieta – you make our team stronger every day.”

Read POEM 2025 Updates on OncoDaily.

Julia Hoveyan

Further Reading:

POEM 2025 Scientific Meeting: Key Sessions, Workshops, and Why You Should Attend

Strengthening the Global Response to Retinoblastoma: Insights from the POEM 4th Scientific Meeting

4th POEM Scientific Meeting cancer Julia Hoveyan OncoDaily Oncology POEM 2025 Ruzanna Papyan
Special Coverage
Blog
May 3, 2025, 08:03
Ruzanna Papyan: Julia Hoveyan on Access to Novel Therapies in the POEM Region at 4th POEM Scientific Meeting
Societies
May 3, 2025, 07:43
HYPO-RT-PC Phase III trial: Two-Week Radiotherapy Proven as Safe and Effective as Eight-Week Course for Prostate Cancer, After 10-Year Follow-Up
Blog
May 3, 2025, 06:07
Icro Meattini: Challenges and Opportunities of Biomarker-Directed Optimisation of Breast Radiotherapy at ESTRO25
Blog
May 3, 2025, 06:03
Joint ESTRO-EORTC Session at ESTRO25
Insight
May 3, 2025, 05:42
FAST-Forward trial 10-year results from ESTRO 2025: Hypofractionated breast radiotherapy for 1 vs 3 weeks
Blog
May 3, 2025, 05:16
Pierre Blanchard: Early Toxicity Results from GETUG Adjuvant Radiotherapy Trial after Cystectomy for Bladder Cancer
Blog
May 3, 2025, 05:04
Paul Sargos: Happy to open this ESTRO25 with the first edition of a pre meeting course on bladder cancer management
Blog
May 3, 2025, 04:57
Gerard Walls: Finally met my ESTRO Mentor Gustavo Ferrari at ESTRO25
Blog
May 3, 2025, 04:47
Nina Niu Sanford: Does radiotherapy have a role in patients with unresectable or medically inoperable gastric cancer?
Blog
May 3, 2025, 04:42
Alizée Camps Maléa: Optimisation of treatment for early breast cancer - A leap out of the box
Blog
May 3, 2025, 04:38
Romualdo Barroso: Sara Tolaney will present the primary results of DESTINY-Breast09 at ASCO 2025
Opinion
May 3, 2025, 04:33
ESOPEC trial updates from ESTRO 2025: Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer